Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.34 | 37.56 |
PEG Ratio (TTM) | 0.14 | -7.00 |
P/S Ratio (TTM) | 0.71 | 7.35 |
P/B Ratio (TTM) | 5.19 | 1.64 |
P/FCF Ratio (TTM) | -2.29 | 22.72 |
Price to 5YR AVG Earnings Ratio | -1.08 | 126.71 |
Price to 5YR AVG FCF Ratio | -1.62 | 93.38 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -49.14% | 4.85% |
ROE (TTM) | -160.79% | -2.05% |
Net Profit Margin (TTM) | -50.09% | 10.68% |
ROIC 5YR AVG | -123.49% | 11.03% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -13.81% | 19.06% | 16.19% |
Revenue | 1.61% | 3.21% | 7.39% |
Net Income | -16.06% | -15.58% | -6.77% |
Cash Flow | -123.15% | -13.25% | -10.76% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.16 | 1.55 |
Quick Ratio (TTM) | 2.87 | 1.19 |
D/E Ratio (TTM) | 4.98 | 0.24 |
Interest Coverage (TTM) | -3.73 | 10.81 |
Piotroski F-Score | 2 | 5 |
Altman Z-Score | N/A | 12.59 |
LTL to 5YR AVG FCF | -1.94 | 2.59 |
Shares Outstanding Growth 5YR AVG | 31.05% | 1.16% |